Literature DB >> 23197412

Dissecting the role of CB1 receptors on chronic liver diseases.

Ramon Bataller1, Bin Gao.   

Abstract

Entities:  

Keywords:  Alcoholic Liver Disease; Oxidative Stress

Mesh：

Substances：

Year:  2012        PMID： 23197412      PMCID： PMC3779466          DOI： 10.1136/gutjnl-2012-303664

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  9 in total

1.  Cannabinoid CB2 receptors protect against alcoholic liver disease by regulating Kupffer cell polarization in mice.

Authors:  Alexandre Louvet; Fatima Teixeira-Clerc; Marie-Noële Chobert; Vanessa Deveaux; Catherine Pavoine; Andreas Zimmer; Françoise Pecker; Ariane Mallat; Sophie Lotersztajn
Journal:  Hepatology       Date:  2011-09-06       Impact factor: 17.425

Review 2.  Nuclear receptors and transcription factors in the development of fatty liver disease.

Authors:  Aurore Vluggens; Janardan K Reddy
Journal:  Curr Drug Metab       Date:  2012-12       Impact factor: 3.731

3.  Estrogen-related receptor γ controls hepatic CB1 receptor-mediated CYP2E1 expression and oxidative liver injury by alcohol.

Authors:  Don-Kyu Kim; Yong-Hoon Kim; Hyun-Hee Jang; Jinyoung Park; Jung Ran Kim; Minseob Koh; Won-Il Jeong; Seung-Hoi Koo; Tae-Sik Park; Chul-Ho Yun; Seung Bum Park; John Y L Chiang; Chul-Ho Lee; Hueng-Sik Choi
Journal:  Gut       Date:  2012-09-29       Impact factor: 23.059

Review 4.  Alcoholic liver disease: pathogenesis and new therapeutic targets.

Authors:  Bin Gao; Ramon Bataller
Journal:  Gastroenterology       Date:  2011-09-12       Impact factor: 22.682

Review 5.  Endocannabinoids in liver disease.

Authors:  Joseph Tam; Jie Liu; Bani Mukhopadhyay; Resat Cinar; Grzegorz Godlewski; George Kunos
Journal:  Hepatology       Date:  2011-01       Impact factor: 17.425

6.  Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice.

Authors:  Douglas Osei-Hyiaman; Jie Liu; Liang Zhou; Grzegorz Godlewski; Judith Harvey-White; Won-il Jeong; Sándor Bátkai; Giovanni Marsicano; Beat Lutz; Christoph Buettner; George Kunos
Journal:  J Clin Invest       Date:  2008-09       Impact factor: 14.808

Review 7.  Should peripheral CB(1) cannabinoid receptors be selectively targeted for therapeutic gain?

Authors:  George Kunos; Douglas Osei-Hyiaman; Sándor Bátkai; Keith A Sharkey; Alexandros Makriyannis
Journal:  Trends Pharmacol Sci       Date:  2008-11-29       Impact factor: 14.819

8.  Paracrine activation of hepatic CB1 receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver.

Authors:  Won-il Jeong; Douglas Osei-Hyiaman; Ogyi Park; Jie Liu; Sándor Bátkai; Partha Mukhopadhyay; Norio Horiguchi; Judith Harvey-White; Giovanni Marsicano; Beat Lutz; Bin Gao; George Kunos
Journal:  Cell Metab       Date:  2008-03       Impact factor: 27.287

Review 9.  CYP2E1 and oxidant stress in alcoholic and non-alcoholic fatty liver disease.

Authors:  Tung-Ming Leung; Natalia Nieto
Journal:  J Hepatol       Date:  2012-08-28       Impact factor: 25.083
  9 in total
  1 in total

1.  Orphan nuclear receptor oestrogen-related receptor γ (ERRγ) plays a key role in hepatic cannabinoid receptor type 1-mediated induction of CYP7A1 gene expression.

Authors:  Yaochen Zhang; Don-Kyu Kim; Ji-Min Lee; Seung Bum Park; Won-Il Jeong; Seong Heon Kim; In-Kyu Lee; Chul-Ho Lee; John Y L Chiang; Hueng-Sik Choi
Journal:  Biochem J       Date:  2015-06-29       Impact factor: 3.857
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.